series-a
Stage
2
Investors
About
Surrozen develops regenerative therapeutics by engineering multifunctional antibodies that modulate Wnt signaling to promote tissue repair, focusing primarily on treating ophthalmic diseases.
Explore Surrozen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.